Rondaxe Enterprises Revenue and Competitors
Estimated Revenue & Valuation
- Rondaxe Enterprises's estimated annual revenue is currently $3.2M per year.
- Rondaxe Enterprises's estimated revenue per employee is $201,000
Employee Data
- Rondaxe Enterprises has 16 Employees.
- Rondaxe Enterprises grew their employee count by -6% last year.
Rondaxe Enterprises's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Software Development | Reveal Email/Phone |
3 | Director Technical Services | Reveal Email/Phone |
4 | Chemistry Development | Reveal Email/Phone |
5 | International Sourcing/Business Development | Reveal Email/Phone |
Rondaxe Enterprises Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.6M | 49 | 2% | N/A | N/A |
What Is Rondaxe Enterprises?
Rondaxe Enterprises is a unique company providing a suite of services that combines expert drug development consulting, in-depth project management leadership, software applications and virtual business development designed specifically for emerging pharmaceutical and biotech companies. Rondaxe is led by four managing members, a team of experienced industry executives and more than 50 senior advisors, most of whom have 15-30 plus years of industry experience, with a vision and an unflinching dedication to clients’ success. Founded in 2003, Rondaxe has enjoyed steady growth based on a proven track record in delivering results, establishing solid relationships with customers, and a strong commitment to expand skills and product offerings as customer’s needs expand. For more information, visit www.rondaxe.com.
keywords:N/AN/A
Total Funding
16
Number of Employees
$3.2M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.6M | 16 | 0% | N/A |
#2 | $1.4M | 16 | 7% | N/A |
#3 | $2.5M | 17 | 6% | N/A |
#4 | N/A | 17 | 6% | N/A |
#5 | $2.9M | 18 | -59% | N/A |